Skip to content

Investigating the Causal Role of Prefrontal Control in Decision-making in Patients With Anhedonia

Causal Role of Delta-beta Coupling for Goal-directed Behavior in Anhedonia

Status
Completed
Phases
NA
Study type
Interventional
Source
ClinicalTrials.gov
Registry ID
NCT05084924
Acronym
DEBRA
Enrollment
35
Registered
2021-10-20
Start date
2021-11-02
Completion date
2023-07-31
Last updated
2024-06-25

For informational purposes only — not medical advice. Sourced from public registries and may not reflect the latest updates. Terms

Conditions

Anhedonia, Major Depressive Disorder

Keywords

transcranial Alternating Current Stimulation, Goal-directed behavior, Cross-frequency coupling, Reward-based decision-making

Brief summary

Investigating whether delta-beta cross-frequency transcranial alternating current stimulation can increase goal-directed behavior in participants with major depressive disorder and elevated symptoms of anhedonia.

Detailed description

The purpose of this clinical trial is to investigate the causal role that delta-beta coupling plays in goal-directed behavior in participants with major depressive disorder (MDD) and symptoms of anhedonia. The participants will perform a reward-based decision-making task. During the task, cross-frequency transcranial alternating current stimulation (tACS) will be delivered at delta-beta frequency, a control-frequency, or an active sham. Electroencephalography will be collected in intermittent resting-state periods. Structural and functional magnetic resonance imaging (MRI) will be collected during the resting-state and during performance of the task.

Interventions

DEVICECross-frequency transcranial alternating current stimulation via the NeuroConn Direct Current Stimulator Plus

Stimulation will be delivered via the NeuroConn Direct Current Stimulator Plus, an investigational electrical non-invasive brain stimulation device that is being used for foundational neuroscience and translational research.

Sponsors

National Institute of Mental Health (NIMH)
CollaboratorNIH
University of North Carolina, Chapel Hill
Lead SponsorOTHER

Study design

Allocation
RANDOMIZED
Intervention model
PARALLEL
Primary purpose
BASIC_SCIENCE
Masking
DOUBLE (Subject, Investigator)

Masking description

This study is designed to be double-blind. Participants and the researchers are unaware of each participant's assignment until the completion of all data collection. This is accomplished using randomization codes. Furthermore, this study utilizes an active sham stimulation. This means that the active sham condition includes some stimulation, mimicking the skin sensations associated with tACS. In a previously concluded trial, participants in the delta-beta tACS, theta-gamma tACS, and active sham groups responded similarly to the blinding questionnaire, indicating that the active sham stimulation successfully blinded the participants.

Intervention model description

Participants are randomized into one of three arms of the study: delta-beta tACS, control tACS in theta-gamma, or active sham. Randomization is stratified by SHAPS level such that there are an equal number of participants that are high anhedonia (SHAPS \> 33) and low anhedonia (SHAPS \<=33).

Eligibility

Sex/Gender
ALL
Age
18 Years to 65 Years
Healthy volunteers
No

Inclusion criteria

* Able to provide informed consent * Have normal to corrected vision * Willing to comply with all study procedures and be available for the duration of the study * Speak and understand English * Low suicide risk as determined by the Columbia Suicide Severity Rating Scale (C-SSRS), and by the Hamilton Depression Rating Scale (HAM-D; less than 3 for the suicidality item). * Negative pregnancy test for female participants * Patient Health Questionnaire (PHQ) with 9 items greater than or equal to 10 and a diagnosis of major depressive disorder on the Mini International Neuropsychiatric Interview (MINI)

Exclusion criteria

* Attention deficit (hyperactivity) disorder (currently under treatment) * Neurological disorders and conditions, including, but not limited to: History of epilepsy, seizures (except childhood febrile seizures), dementia, history of stroke, Parkinson's disease, multiple sclerosis, cerebral aneurysm, brain tumors * Medical or neurological illness or treatment for a medical disorder that could interfere with study participation (e.g., unstable cardiac disease, HIV/AIDS, malignancy, liver or renal impairment) * Prior brain surgery * Any brain devices/implants, including cochlear implants and aneurysm clips * History of current traumatic brain injury * (For females) Pregnant or breast feeding * Anything that, in the opinion of the investigator, would place the participant at increased risk or preclude the participant's full compliance with or completion of the study * Diagnostic and Statistical Manual of Mental Disorders version 5 diagnosis of present moderate or severe substance use disorder or alcohol use disorder, and past severe substance use disorder or alcohol use disorder, or psychotic disorder within the last 12 months * Not taking medications for attention deficit (hyperactivity) disorder or benzodiazepines as these medications often produce specific EEG activity that may disrupt our interpretation of the findings * If major depressive disorder is experienced in episode, the participant must currently be within a depressive episode. * Contraindications for magnetic resonance imaging (MRI): ferrous metal inside the body, jewelry must be removable, pacemaker or cochlear implant.

Design outcomes

Primary

MeasureTime frameDescription
Change in the Percentage of Trials That the Participant Chooses to Perform the Hard TaskBaseline (Hour 1), Stimulation (Hours 2 through 3)In the Expenditure of Effort for Reward Task, participants are faced with a decision on every trial: to choose an easy task with a low effort exertion for a chance at winning a low amount of money or a hard task with a high effort exertion for a chance at winning a greater amount of money. The incentive for the high effort exertion is changed on each trial and the participant gets physically tired from repeated effort exertion. Goal-directed behavior was calculated as the percentage of trials in which the participant decides to perform the high effort exertion. The average of the 4 blocks prior to stimulation served as a baseline (1st hour). The effect of the intervention was the average of the next 8 blocks during stimulation (hours 2 through 3).

Secondary

MeasureTime frameDescription
Change in Coupling Strength Between Low-frequency Prefrontal Signals and High-frequency Posterior SignalsBaseline (Hour 1), Stimulation (Hours 2 through 3)Coupling strength was estimated using the Mean Vector Length calculation between the phase of low-frequency electrical activity in prefrontal electrodes and amplitude of high-frequency activity in posterior cortex. A hybrid signal was created using high-frequency amplitude and low-frequency phase. The magnitude of the average of this signal over time is the coupling strength. Coupling strength was normalized using a z-transformation relative to a null distribution generated by randomly time-shifting the high-frequency data relative to the low-frequency data (z-score). A value of zero represents no coupling. A higher value represents greater coupling strength, which is generally associated with better cognition. Values range from -3 to 3 and a score greater than 1.6 means the coupling is present. The average of the 4 blocks prior to stimulation served as a baseline (1st hour). The effect of the intervention was the average of the next 8 blocks during stimulation (hours 2 through 3).

Countries

United States

Participant flow

Participants by arm

ArmCount
Delta-beta tACS
The study is investigating the use of transcranial alternating current stimulation (tACS). The stimulation is delivered at 1 milliampere (mA) zero-to-peak amplitude at the target electrodes and 2 mA zero to-peak amplitude at the return electrode. For the experimental arm, the tACS will be delivered using the cross-frequency stimulation waveform delta-beta (3-20Hz). Cross-frequency transcranial alternating current stimulation via the NeuroConn Direct Current Stimulator Plus: Stimulation will be delivered via the NeuroConn Direct Current Stimulator Plus, an investigational electrical non-invasive brain stimulation device that is being used for foundational neuroscience and translational research.
11
Theta-gamma tACS
This arm serves as an active control where tACS will be delivered using the cross-frequency stimulation waveform theta-gamma (5-50Hz). Cross-frequency transcranial alternating current stimulation via the NeuroConn Direct Current Stimulator Plus: Stimulation will be delivered via the NeuroConn Direct Current Stimulator Plus, an investigational electrical non-invasive brain stimulation device that is being used for foundational neuroscience and translational research.
12
Active-sham tACS
For active sham stimulation, either delta-beta or theta-gamma stimulation is delivered for 10 seconds and then returns to baseline. This is intended to mimic the skin sensations (e.g., itching, burning, tingling) that are experienced at the onset of stimulation, assisting with blinding the participant's assignment. Cross-frequency transcranial alternating current stimulation via the NeuroConn Direct Current Stimulator Plus: Stimulation will be delivered via the NeuroConn Direct Current Stimulator Plus, an investigational electrical non-invasive brain stimulation device that is being used for foundational neuroscience and translational research.
12
Total35

Baseline characteristics

CharacteristicDelta-beta tACSTheta-gamma tACSActive-sham tACSTotal
Age, Categorical
<=18 years
0 Participants0 Participants0 Participants0 Participants
Age, Categorical
>=65 years
0 Participants0 Participants0 Participants0 Participants
Age, Categorical
Between 18 and 65 years
11 Participants12 Participants12 Participants35 Participants
Age, Continuous27.8 years
STANDARD_DEVIATION 12.9
27.0 years
STANDARD_DEVIATION 10.3
31.8 years
STANDARD_DEVIATION 15.6
28.9 years
STANDARD_DEVIATION 12.9
Ethnicity (NIH/OMB)
Hispanic or Latino
1 Participants0 Participants1 Participants2 Participants
Ethnicity (NIH/OMB)
Not Hispanic or Latino
10 Participants12 Participants11 Participants33 Participants
Ethnicity (NIH/OMB)
Unknown or Not Reported
0 Participants0 Participants0 Participants0 Participants
Race (NIH/OMB)
American Indian or Alaska Native
0 Participants0 Participants0 Participants0 Participants
Race (NIH/OMB)
Asian
1 Participants0 Participants2 Participants3 Participants
Race (NIH/OMB)
Black or African American
0 Participants1 Participants0 Participants1 Participants
Race (NIH/OMB)
More than one race
1 Participants1 Participants0 Participants2 Participants
Race (NIH/OMB)
Native Hawaiian or Other Pacific Islander
0 Participants0 Participants0 Participants0 Participants
Race (NIH/OMB)
Unknown or Not Reported
0 Participants0 Participants0 Participants0 Participants
Race (NIH/OMB)
White
9 Participants10 Participants10 Participants29 Participants
Region of Enrollment
United States
11 Participants12 Participants12 Participants35 Participants
Sex: Female, Male
Female
9 Participants9 Participants8 Participants26 Participants
Sex: Female, Male
Male
2 Participants3 Participants4 Participants9 Participants

Adverse events

Event typeEG000
affected / at risk
EG001
affected / at risk
EG002
affected / at risk
deaths
Total, all-cause mortality
0 / 110 / 120 / 12
other
Total, other adverse events
3 / 113 / 121 / 12
serious
Total, serious adverse events
0 / 110 / 120 / 12

Outcome results

Primary

Change in the Percentage of Trials That the Participant Chooses to Perform the Hard Task

In the Expenditure of Effort for Reward Task, participants are faced with a decision on every trial: to choose an easy task with a low effort exertion for a chance at winning a low amount of money or a hard task with a high effort exertion for a chance at winning a greater amount of money. The incentive for the high effort exertion is changed on each trial and the participant gets physically tired from repeated effort exertion. Goal-directed behavior was calculated as the percentage of trials in which the participant decides to perform the high effort exertion. The average of the 4 blocks prior to stimulation served as a baseline (1st hour). The effect of the intervention was the average of the next 8 blocks during stimulation (hours 2 through 3).

Time frame: Baseline (Hour 1), Stimulation (Hours 2 through 3)

ArmMeasureValue (MEAN)Dispersion
Delta-beta tACSChange in the Percentage of Trials That the Participant Chooses to Perform the Hard Task-0.30 percentage of trialsStandard Deviation 0.15
Theta-gamma tACSChange in the Percentage of Trials That the Participant Chooses to Perform the Hard Task-0.22 percentage of trialsStandard Deviation 0.12
Active-sham tACSChange in the Percentage of Trials That the Participant Chooses to Perform the Hard Task-0.09 percentage of trialsStandard Deviation 0.29
p-value: 0.049ANOVA
Secondary

Change in Coupling Strength Between Low-frequency Prefrontal Signals and High-frequency Posterior Signals

Coupling strength was estimated using the Mean Vector Length calculation between the phase of low-frequency electrical activity in prefrontal electrodes and amplitude of high-frequency activity in posterior cortex. A hybrid signal was created using high-frequency amplitude and low-frequency phase. The magnitude of the average of this signal over time is the coupling strength. Coupling strength was normalized using a z-transformation relative to a null distribution generated by randomly time-shifting the high-frequency data relative to the low-frequency data (z-score). A value of zero represents no coupling. A higher value represents greater coupling strength, which is generally associated with better cognition. Values range from -3 to 3 and a score greater than 1.6 means the coupling is present. The average of the 4 blocks prior to stimulation served as a baseline (1st hour). The effect of the intervention was the average of the next 8 blocks during stimulation (hours 2 through 3).

Time frame: Baseline (Hour 1), Stimulation (Hours 2 through 3)

ArmMeasureValue (MEAN)Dispersion
Delta-beta tACSChange in Coupling Strength Between Low-frequency Prefrontal Signals and High-frequency Posterior Signals0.95 Z-scoreStandard Deviation 0.68
Theta-gamma tACSChange in Coupling Strength Between Low-frequency Prefrontal Signals and High-frequency Posterior Signals-0.97 Z-scoreStandard Deviation 1.04
Active-sham tACSChange in Coupling Strength Between Low-frequency Prefrontal Signals and High-frequency Posterior Signals0.13 Z-scoreStandard Deviation 1.78
p-value: 0.004ANOVA

Source: ClinicalTrials.gov · Data processed: Feb 4, 2026